Benchmark PreciseInhale

PreciseInhale’s unique versatility, combined with one-animal-at-a-time testing lets inhalation drug developers accelerate drug development timelines and increase quality of data. Compare PreciseInhale to the alternatives, and explore the quality, control and cost benefits.
Read more about Benchmark PreciseInhale

Range and aerosol exposures

PreciseInhale generates a very fine powder aerosol, evenly delivered, through intratracheal or nose-only exposures.

Active dosing increases research control and reduces costs

PreciseInhale allows researchers to individually control doses based on aerosol concentration and animal ventilation.

Active dosing produces high-precision data

Active dosing lets researchers choose which Candidate Drugs to continue and which to eliminate before entering the regulatory bodies.